Latest

Neurology

·November 9, 2024·6 min read

AI Tool Reveals Long COVID May Affect 23% of People

A new AI tool identified long COVID in 22.8% of patients, a much higher rate than previously diagnosed. By analyzing extensive health records from nearly 300,000 patients, the algorithm identifies long COVID by distinguishing symptoms linked specifically to SARS-CoV-2 infection rather than pre-existing conditions. This AI approach, known as "precision phenotyping," helps clinicians differentiate long COVID symptoms from other health issues and may improve diagnostic accuracy by about 3%.

Featured Neurology Neuroscience

·November 8, 2024·6 min read

Pathway Identified for Early Intervention in ALS Progression

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing neuron degeneration. By targeting the RNA-binding protein SmD1, scientists were able to prevent key ALS proteins from leaving their protective cellular zones, preserving neuron function. The findings may lead to ALS therapies capable of halting progression before significant neurodegeneration occurs, offering potential new strategies against the disease.

This shows a doctor looking at brain scans.

Brain Cancer Featured Neurology Neuroscience

·November 7, 2024·4 min read

Novel Vaccine Targets Deadly Brain Tumors with Precision

A novel vaccine can mobilize the immune system to precisely target and attack cancerous brain tumors, specifically gliomas, one of the deadliest brain tumor types. This groundbreaking work demonstrates that the body’s immune system can be directed to target proteins with cancer-driving mutations in tumors, marking a significant advance in immunotherapy.

Featured Neurology Neuroscience

·November 7, 2024·4 min read

New Nasal Spray Could Delay Alzheimer’s Progression by Years

Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially delaying its progression by over a decade. Using extracellular vesicles derived from neural stem cells, the treatment reduced inflammation and protein build-up in the brain in early-stage Alzheimer’s animal models.

This shows a man's face and broken bottles.

Featured Genetics Neurology Neuroscience

·November 5, 2024·5 min read

Gene Study Links Alcohol Addiction to Accelerated Alzheimer’s Progression

Researchers discovered alcohol use disorder (AUD) and Alzheimer's disease (AD) exhibit similar patterns of gene dysregulation, hinting that alcohol consumption may hasten Alzheimer’s progression. By analyzing gene expression across individual brain cells, the team found shared disruptions in inflammation, cell signaling, and blood vessel functions in both disorders.

This shows a brain and a graduation cap.

Featured Neuroscience

·November 5, 2024·5 min read

Does Additional Education Protect the Brain?

A recent study explored whether additional years of education lead to long-term changes in brain structure, especially in protecting against brain aging. Analyzing data from a unique natural experiment involving nearly 30,000 individuals, researchers found no detectable impact on brain structure from an additional year of education. Although education is linked to better cognitive skills and health, it does not appear to alter the brain’s physical structure in the long run.

Featured Neurology Neuroscience

·November 4, 2024·4 min read

Keto Diet May Ease Multiple Sclerosis Symptoms

New research suggests the ketogenic diet could help manage multiple sclerosis (MS) by promoting the production of beneficial compounds in the gut. In a study, mice on a keto diet produced the ketone body β-hydroxybutyrate (βHB), which worked with gut bacteria to create immune-modulating metabolites.

Brain Cancer Featured Neurology Neuroscience

·November 4, 2024·4 min read

Omega-3 and 6 Linked to Lower Cancer Risk

Higher levels of omega-3 and omega-6 fatty acids are linked with a lower risk of several types of cancer, including brain, colon, stomach, and lung cancer, according to a study of over 250,000 participants. The findings highlight the potential of these "healthy fats" in cancer prevention, regardless of BMI or lifestyle. The study also suggests that omega-6 benefits are particularly effective for younger adults, especially women. Results open the door to dietary adjustments that may aid in reducing cancer risk.

Featured Neurology Neuroscience

·November 4, 2024·8 min read

Lower Blood Sugar Diet Linked to Slower Brain Aging

The Green Mediterranean diet may help slow brain aging by controlling blood sugar levels, benefiting cognitive health in older adults. The study found that lower blood sugar levels were linked to a younger brain age, particularly in regions critical for memory and sensory processing. Using advanced MRI scans, researchers observed that participants on the Green-Med diet exhibited a slower rate of brain atrophy over 18 months.

Brain Cancer Featured Neurology Neuroscience

·November 4, 2024·5 min read

New Cell Targets Offer Hope for Treating Glioblastoma

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this aggressive brain cancer. By analyzing stem cells derived from patient tumors, scientists found two primary cell subtypes responsible for tumor growth, each with unique vulnerabilities.

Featured Genetics Neurology Neuroscience

·November 3, 2024·3 min read

RNA Structures Linked to Parkinson’s Protein Aggregates

Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein aggregation linked to neurodegenerative diseases like Parkinson’s. Elevated calcium levels trigger these G4s, acting as "scaffolds" for α-synuclein clumping. Administering 5-aminolevulinic acid (5-ALA) to model mice prevented aggregation and reduced motor symptoms. This breakthrough suggests that G4-targeted therapies could offer early intervention for neurodegenerative diseases.

Featured Neurology Neuroscience

·November 2, 2024·8 min read

New Blood Test Shows Promise for Early Parkinson’s Detection

Researchers have developed a method to analyze extracellular vesicles (EVs) in blood for early detection of Parkinson’s disease (PD). By isolating EVs and assessing their contents, the team identified a protein called phosphorylated α-synuclein that appears in elevated levels in PD patients.

1 … 42 43 44 45 46 … 604

Neurology

AI Tool Reveals Long COVID May Affect 23% of People

Pathway Identified for Early Intervention in ALS Progression

Novel Vaccine Targets Deadly Brain Tumors with Precision

New Nasal Spray Could Delay Alzheimer’s Progression by Years

Gene Study Links Alcohol Addiction to Accelerated Alzheimer’s Progression

Does Additional Education Protect the Brain?

Keto Diet May Ease Multiple Sclerosis Symptoms

Omega-3 and 6 Linked to Lower Cancer Risk

Lower Blood Sugar Diet Linked to Slower Brain Aging

New Cell Targets Offer Hope for Treating Glioblastoma

RNA Structures Linked to Parkinson’s Protein Aggregates

New Blood Test Shows Promise for Early Parkinson’s Detection

Individual Cone Cells Create Our Sharpest Sight

How Your Neighborhood and Nation Shape Your Brain’s Age

Alzheimer’s Risk Gene Shrinks Neurons

Noninvasive Stimulation “Talks” to the Brain’s Memory Center

Subscribe